Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy.
Zink A, Dai DF, Wittich A, Henke MT, Pedrotti G, Heiduschka S, Santamaria G, Pentimalli TM, Brueser C, Notopoulou S, Umar AR, Zhaivoron A, Petersilie L, Jerred C, Bergmans J, Neu LA, Schumacher F, Keller-Findeisen J, Rybak-Wolf A, Stach D, Reinshagen J, Haferkamp U, Krieg K, Zaliani A, Euro L, Di Donfrancesco A, Santanatoglia C, Cappellozza E, Suarez Cubero M, Pavez-Giani M, Bakumenko O, Meierhofer D, Foley A, Morales-Gonzalez S, Tolle I, Herebian D, Bonesso D, Cecchetto G, Wong SN, Moresco M, Maresca A, Decimo I, De Sanctis F, Adamo A, Adjobo-Hermans MJW, Duchi R, Barandalla M, Scaglia M, Perota A, Galli C, Kleuser B, Cyganek L, Mühlhausen C, Schlotawa L, Tiranti V, Mayatepek E, Szabo I, La Morgia C, Klopstock T, Carelli V, Distelmaier F, Rossi A, Rajewsky N, Ullah G, Jakobs S, Rose CR, Petrakis S, Edenhofer F, Koopman WJH, Lisowski P, Suomalainen A, Brunetti D, Del Sol A, Bottani E, Pless O, Schuelke M, Prigione A.
Zink A, et al. Among authors: carelli v.
Cell. 2026 Mar 11:S0092-8674(26)00173-X. doi: 10.1016/j.cell.2026.02.008. Online ahead of print.
Cell. 2026.
PMID: 41819105
Free article.